section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
section 1 - World Intellectual Property Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
37/2000<br />
14 Sep/sep 2000 PCT Gazette - Section I - Gazette du PCT 13243<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CR CU CZ DE DK DM EE ES<br />
FI GB GD GE GH GM HR HU ID IL IN<br />
IS JP KE KG KR KZ LC LK LR LS LT LU<br />
LV MA MD MG MK MN MW MX NO NZ<br />
PL PT RO RU SD SE SG SI SK SL TJ TM<br />
TR TT TZ UA UG US UZ VN YU ZA ZW;<br />
AP (GH GM KE LS MW SD SL SZ TZ UG<br />
ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF<br />
BJ CF CG CI CM GA GN GW ML MR NE<br />
SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 C07D 473/16, 473/18, A61K 31/52,<br />
31/522<br />
(11) WO 00/53603 (13) A1<br />
(21) PCT/US00/06250<br />
(22) 10 Mar/mar 2000 (10.03.2000)<br />
(25) en (26) en<br />
(30) 09/267,839 12 Mar/mar 1999<br />
(12.03.1999)<br />
US<br />
(43) 14 Sep/sep 2000 (14.09.2000)<br />
(54) 2–HYDROXY METHYLCYCLOPRO<br />
PYLIDENEMETHYL PURINES AND<br />
–PYRIMIDINES AS ANTIVIRAL<br />
AGENTS<br />
2–HYDROXY METHYLCYCLOPRO<br />
PYLIDENEMETHYL PURINES ET<br />
PYRIMIDINES COMME AGENTS AN-<br />
TIVIRAUX<br />
(71) THE REGENTS OF THE UNIVERSITY<br />
OF MICHIGAN [US/US]; Wolverine Tower,<br />
Room 2071, 3003 S. State Street,<br />
Ann Arbor, MI 48109–1280 (US). WAYNE<br />
STATE UNIVERSITY [US/US]; 656 W.<br />
Kirby, 4249 F.A.B, Detroit, MI 48202 (US).<br />
(72) ZEMLICKA, Jiri; 2025 Common, Warren,<br />
MI 48092 (US). QIU, Yao–Ling; Apartment<br />
#1304, 5200 Anthony Wayne Drive, Detroit,<br />
MI 48202 (US). DRACH, John, C.; 1372<br />
Barrister Road, Ann Arbor, MI 48105 (US).<br />
PTAK, Roger, G.; Apartment #103, 741<br />
Valley Circle Drive, Saline, MI 48176 (US).<br />
(74) SMITH, DeAnn, F. et al. / etc.; Lahive &<br />
Cockfield, LLP, 28 State Street, Boston, MA<br />
02109 (US).<br />
(81) CA JP; EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE).<br />
(51) 7 C07D 473/34, 487/04, 211/78, 207/34,<br />
A61K 31/52, 31/519, A61P 43/00, 25/24,<br />
25/22, 25/28, 25/16, 25/30, 25/08, 1/00,<br />
7/10, 9/10, 9/12, 17/02, 29/00, 37/02<br />
(11) WO 00/53604<br />
(21) PCT/JP00/01468<br />
(13) A1<br />
(22) 10 Mar/mar 2000 (10.03.2000)<br />
(25) ja (26) ja<br />
(30) 11/65004 11 Mar/mar 1999<br />
(11.03.1999)<br />
JP<br />
(30) 11/185628 30 Jun/juin 1999<br />
(30.06.1999)<br />
(30) 11/258353 13 Sep/sep 1999<br />
(13.09.1999)<br />
JP<br />
JP<br />
(43) 14 Sep/sep 2000 (14.09.2000)<br />
(54) CARBAMOYL TETRAHYDROPYRI-<br />
DINE DERIVATIVES<br />
DERIVES DE CARBAMOYL TETRA-<br />
HYDROPYRIDINE<br />
(71) TAISHO PHARMACEUTICAL CO.,<br />
LTD. [JP/JP]; 24–1, Takata 3–chome, Toshima–ku,<br />
Tokyo 170–8633 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) NAKAZATO, Atsuro [JP/JP]; Taisho<br />
Pharmaceutical Co., Ltd., 24–1, Takata<br />
3–chome, Toshima–ku, Tokyo 170–8633<br />
(JP). OKUBO, Taketoshi [JP/JP]; Taisho<br />
Pharmaceutical Co., Ltd., 24–1, Takata<br />
3–chome, Toshima–ku, Tokyo 170–8633<br />
(JP). KUMAGAI, Toshihito [JP/JP]; Taisho<br />
Pharmaceutical Co., Ltd., 24–1, Takata<br />
3–chome, Toshima–ku, Tokyo 170–8633<br />
(JP). TOMISAWA, Kazuyuki [JP/JP]; Taisho<br />
Pharmaceutical Co., Ltd., 24–1, Takata<br />
3–chome,<br />
(JP).<br />
Toshima–ku, Tokyo 170–8633<br />
(74) KITAGAWA, Tomizo; Taisho Pharmaceutical<br />
Co., Ltd., Patent Division, 24–1, Takata<br />
3–chome,<br />
(JP).<br />
Toshima–ku, Tokyo 170–8633<br />
(81) AU CA CN KR US; EP (AT BE CH CY DE<br />
DK ES FI FR GB GR IE IT LU MC NL PT<br />
SE).<br />
(51) 7 C07D 487/04, A61K 31/519<br />
(11) WO 00/53605 (13) A1<br />
(21) PCT/US00/05903<br />
(22) 8 Mar/mar 2000 (08.03.2000)<br />
(25) en (26) en<br />
(30) 60/123,902 11 Mar/mar 1999 US<br />
(11.03.1999)<br />
(43) 14 Sep/sep 2000 (14.09.2000)<br />
(54) TYROSINE KINASE INHIBITORS<br />
INHIBITEURS DE TYROSINE KINASE<br />
(71) MERCK & CO., INC. [US/US]; 126 East<br />
Lincoln Avenue, Rahway, NJ 07065–0907<br />
(US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) BILODEAU, Mark, T. [US/US];<br />
126 East Lincoln Avenue, Rahway, NJ<br />
07065–0907 (US). FRALEY, Mark, E.<br />
[US/US]; 126 East Lincoln Avenue, Rahway,<br />
NJ 07065–0907 (US). HUNGATE,<br />
Randall, W. [US/US]; 126 East Lincoln<br />
Avenue, Rahway, NJ 07065–0907 (US).<br />
(74) MERCK & CO., INC.; 126 East Lincoln<br />
Avenue, Rahway, NJ 07065–0907 (US).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CR CU CZ DE DK DM DZ EE<br />
ES FI GB GD GE GH GM HR HU ID IL IN<br />
IS JP KE KG KR KZ LC LK LR LS LT LU<br />
LV MA MD MG MK MN MW MX NO NZ<br />
PL PT RO RU SD SE SG SI SK SL TJ TM<br />
TR TT TZ UA UG US UZ VN YU ZA ZW;<br />
AP (GH GM KE LS MW SD SL SZ TZ UG<br />
ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH CY DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE); OA (BF<br />
BJ CF CG CI CM GA GN GW ML MR NE<br />
SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 C07D 491/04, A61K 31/44, C07D 213/66,<br />
A61P 9/00<br />
(11) WO 00/53606 (13) A1<br />
(21) PCT/IB00/00255<br />
(22) 7 Mar/mar 2000 (07.03.2000)<br />
(25) en (26) en<br />
(30) 60/123,698 8 Mar/mar 1999<br />
(08.03.1999)<br />
(30) 60/125,881 24 Mar/mar 1999<br />
(24.03.1999)<br />
(43) 14 Sep/sep 2000 (14.09.2000)<br />
US<br />
US<br />
(54) PYRIDOXAL ANALOGUES FOR VI-<br />
TAMIN B–6 DISORDERS<br />
ANALOGUES DE PYRIDOXAL DES-<br />
TINES AUX TROUBLES PROVOQUES<br />
PAR UNE CARENCE EN VITAMINE<br />
B6<br />
(71) MEDICURE INC. [CA/CA]; 62 Scurfield<br />
Boulevard, Winnipeg, Manitoba R3Y 1M5<br />
(CA).<br />
(72) HAQUE, Wasimul; 4832 17th Avenue,<br />
Edmonton, Alberta T6L 2Y7 (CA).<br />
(74) DUBUC, Jean, H. et al. / etc.; Goudreau<br />
Gage Dubuc, The Stock Exchange Tower,<br />
800 Place Victoria, Suite 3400, P.O. Box 242,<br />
Montreal, Quebec H4Z 1E9 (CA).<br />
(81) AE AL AM AT AT (Utility model / modèle<br />
d’utilité) AUAZBABBBGBRBYCACH<br />
CN CR CU CZ CZ (Utility model / modèle<br />
d’utilité) DE DE (Utility model / modèle<br />
d’utilité) DK DK (Utility model / modèle<br />
d’utilité) DM EE EE (Utility model / modèle<br />
d’utilité) ES FI FI (Utility model / modèle<br />
d’utilité) GBGDGEGHGMHRHUIDIL<br />
IN IS JP KE KG KP KR KR (Utility model<br />
/ modèle d’utilité) KZLCLKLRLSLTLU<br />
LV MA MD MG MK MN MW MX NO NZ<br />
PL PT RO RU SD SE SG SI SK SK (Utility<br />
model / modèle d’utilité) SLTJTMTRTT<br />
TZ UA UG UZ VN YU ZA ZW; AP (GH<br />
GM KE LS MW SD SL SZ TZ UG ZW);<br />
EA (AM AZ BY KG KZ MD RU TJ TM);<br />
EP (AT BE CH CY DE DK ES FI FR GB<br />
GR IE IT LU MC NL PT SE); OA (BF BJ<br />
CF CG CI CM GA GN GW ML MR NE SN<br />
TD TG).<br />
(51) 7 C07D 491/22, A61K 31/435 // (C07D<br />
491/22, 311:00, 221:00, 221:00, 209:00)<br />
(11) WO 00/53607 (13) A1<br />
(21) PCT/EP00/01570<br />
(22) 8 Mar/mar 2000 (08.03.2000)<br />
(25) en (26) en<br />
(30) 99830124.6 9 Mar/mar 1999<br />
(09.03.1999)<br />
(43) 14 Sep/sep 2000 (14.09.2000)<br />
EP<br />
(54) CAMPTOTHECIN DERIVATIVES HA-<br />
VING ANTITUMOR ACTIVITY<br />
DERIVES DE CAMPTOTHECINE<br />
AYANT UNE ACTION ANTITUMO-<br />
RALE